Sign In
Buy CERT
$5.60
-0.0200 (-0.356%)
At Close: Jun 03, 2026
Certara to Participate in Upcoming Investor Conferences
08:00am, Friday, 31'st Oct 2025
RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the followi
Certara Expands Biosimulation Market with AI-Driven QSP Platform
04:15pm, Thursday, 30'th Oct 2025
RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quanti
Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for
11:07am, Thursday, 30'th Oct 2025
Certara (CERT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Certara Scientists are Among the Topmost Cited Biopharma Researchers
08:00am, Monday, 20'th Oct 2025
RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research.
Why Investors Should Consider Certara Again
05:55pm, Wednesday, 15'th Oct 2025
Certara posted strong Q1 and Q2 results, with revenue growth and non-GAAP EPS exceeding expectations, driven by biosimulation software and services. Certara's AI-enabled platforms, including the upcom
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
08:00am, Friday, 10'th Oct 2025
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 afte
Final Trade: CERT, GDX, IWM, MPC
06:34pm, Tuesday, 23'rd Sep 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Certara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
02:40pm, Wednesday, 10'th Sep 2025
Certara, Inc. (NASDAQ:CERT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants John Gallagher - SVP, Principal Accounting Officer & Chief Fin
Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)
12:21pm, Tuesday, 09'th Sep 2025
Certara, Inc. (NASDAQ:CERT ) Baird Global Healthcare Conference 2025 September 9, 2025 10:15 AM EDT Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Off
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
08:00am, Thursday, 04'th Sep 2025
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the availability of Pinnacle 21 Enterprise Plus.
Certara to Participate in Upcoming Investor Conferences
04:15pm, Tuesday, 02'nd Sep 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the follow
Cerrado Gold Inc. (CRDOF) Q2 2025 Earnings Call Transcript
01:32pm, Monday, 25'th Aug 2025
Cerrado Gold Inc. (OTCQX:CRDOF) Q2 2025 Earnings Conference Call August 25, 2025 11:00 AM ET Company Participants Michael McAllister - Vice President of Investor Relations Mark Peter Brennan - CEO & C
Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript
10:24pm, Wednesday, 06'th Aug 2025
Certara, Inc. (NASDAQ:CERT ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants John E. Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer William F.
Certara (CERT) Q2 Revenue Jumps 12%
09:13pm, Wednesday, 06'th Aug 2025
Certara (CERT -3.35%), a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue b
Certara, Inc. (CERT) Q2 Earnings Miss Estimates
07:01pm, Wednesday, 06'th Aug 2025
Certara, Inc. (CERT) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.07 per share a year ago.
